NRX Pharmaceuticals(NRXP) - 2024 Q1 - Quarterly Results
NRX Pharmaceuticals(NRXP)2024-05-16 00:16RADNOR, Pa., May 14, 2024 – NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced its financial results for the quarter ended March 31, 2024, and provided a business update. Exhibit 99.1 NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2024 Financial Results and Provides Business Update 2024 Catalysts: Positive Clinical Data, Two Planned NDAs, Company Launch of Hope Therapeutics; FDA QIDP award in cUTI and New Schi ...